“April 2017 : Intensification of the Company’s international development with the appointment of a new CEO : Mrs Nawal Ouzren”
“Sensorion aims to become a major player in the development of inner ear disease treatments of and thus fulfill unmet medical needs”
"Our mission is to develop innovative and targeted treatments for inner ear diseases with vertigo, tinnitus, hearing loss"
" Sensorion, has received “French Tech Pass” certification, and thus joins an exclusive circle of innovative French technology companies with substantial development potential"

Bio Management Team

 

Pierre Attali

Pierre Attali

Medical Director

Paul Bikard

Paul Bikard

Director of Finance and Administration

Jonas Dyhrfjeld-Johnsen

Jonas Dyhrfjeld-Johnsen

Head of Pharmacology

Aurore Brugeaud

Aurore Brugeaud

Operations Manager